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Abstract A cDNA clone for sapecin B, an antibacterial protein 
of Sarcophaga, was isolated. This cDNA encoded a precursor 
protein of sapecin B consisting of a signal sequence (24 residues), 
prosegment (30 residues) and mature sapecin B (34 residues). 
Sapecin B was synthesized almost exclusively in the fat body 
when the larval body wall was injured, but the brain of naive 
larvae was also demonstrated to contain a significant amount of 
sapecin B. These findings suggested that sapecin B is a bifunc- 
tional protein. 
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1. Introduction 
Dipteran insects are known to have the ability to induce 
antibacterial proteins in response to bacterial infection or body 
injury [1-3]. Sapecin is one of these antibacterial proteins of 
Sarcophaga peregrina (flesh fly), and has been shown to have 
potent antibacterial activity against various bacteria [4]. Re- 
cently, we purified two sapecin homologues named sapecin B 
and C from this insect [5]. Sapecin and sapecin C each consisted 
of 40 amino acid residues, and show 78% sequence identity, 
whereas, sapecin B consisted of 34 residues, and its maximum 
sequence identity with sapecin is 41%, indicating that sapecin 
B is less similar than sapecin C to sapecin. 
On the other hand, significant similarity was found between 
sapecin B and charybdotoxin (a scorpion venom toxin) [5]. On 
alignment to give maximum matching, 11 of its 34 residues were 
shown to be identical with those of charybdotoxin. Moreover, 
like charybdotoxin, sapecin B was found to be a potent inhib- 
itor of calcium-activated potassium channels of rat cerebella 
Purkinje cells [6]. These findings suggested that sapecin B is a 
bifunctional molecule: one function is to kill infecting bacteria 
in the acute phase and the other to regulate potassium currents 
in the brain [7]. 
This paper reports molecular cloning of sapecin B cDNA.  
The structural organization of  sapecin B cDNA was the same 
as that of sapecin cDNA, suggesting that these two genes are 
derived from a common ancestral gene [8]. However, only sape- 
cin B was detected in the brain of naive larvae, although both 
sapecin and sapecin B are induced in response to larval body 
injury. 
*Corresponding author. Fax: (81) (3) 5684-2973. 
2. Materials and methods 
2.1. Experimental materials' 
Third instar larvae of Sarcophaga were used. Hemolymph and he- 
mocytes were collected as described before [9]. The fat body and brain 
were excised from the larvae with fine forceps under a binocular micro- 
scope. For enhancement of defense mechanism, larvae were pricked 
with a hypodermic needle. An embryonic cell line of Sareophaga, NIH- 
Sape-4, was routinely cultured in M-M medium [10]. Sapecin was puri- 
fied from the culture medium of NIH-Sape-4 as described before [4]. 
Sapecin B was synthesized chemically [11]. 
2.2. Cloning of sapecin B cDNA 
As NIH-Sape-4 cells are known to synthesize sapecin B constitu- 
tively, a cDNA library of NIH-Sape-4 cells was constructed by the 
method of Okayama nd Berg [12]. The cloning strategy is shown in 
Fig. 1. Based on the amino acid sequence of sapecin B, two primers, 
N1 and CI, were synthesized. The polymerase chain reaction (PCR) 
was performed with these primers using the cDNA library of NIH- 
Sape-4 as template, and the nucleotide sequence of the resulting PCR 
product was determined. Based on this sequence, two other primers, N2 
and C2, were synthesized. In addition to these primers, two primers 
derived from Okayama nd Berg vector (F and R) were synthesized. 
PCR was performed with combinations of N2 and R, and C2 and F, 
respectively. From these PCR products, sequences of the 5' and 3' 
regions of sapecin B cDNA were determined. Finally, PCR was per- 
formed using two primers N (5'ACTCTTCTTGAAACTATTCA3', 
sense strand) and C (3'TTTCAAACATCTACACATGT5', antisense 
strand) that correspond to the 5' and 3' end of sapecin B cDNA, 
respectively. This PCR product was cloned and the complete sequence 
of sapecin B cDNA was determined. 
2.3. Northern blot hybridization 
This was done essentially as described before [8]. Electrophoresis of
RNA (10/1g/lane) was performed in horizontal slab 1.2% agarose gel 
containing 2.2 M formaldehyde in 20 mM morpholinopropanesulfonic 
acid, 5 mM sodium acetate, and 1 mM EDTA (pH 7.0). After electro- 
phoresis, RNA was blotted onto nitrocellulose filters. Hybridization 
was performed in 50% (v/v) formamide/5 x SSC/5 x Denhaldt's solu- 
tion/sonicated salmon sperm DNA solution (50 ~g/ml) for 18 h at 42 ° C. 
Then the filters were washed and autoradiographed. Sapecin cDNA 
and sapecin B cDNA were used as probes. 
2.4. Radioimmunoassay 
We have reported radioimmunoassay of sapecin [13]. Radioimmu- 
noassay of sapecin B was performed essentially according to our previ- 
ous procedure. Antibody against sapecin B did not cross-react immu- 
nologically with sapecin and vice versa. However, for safety, we used 
affinity-purified antibody as described before [14]. Radioiodination of
sapecin B was performed by a modification of the method of Hunter 
and Greenwood [15]. Labeled sapecin (104 cpm), antibody and serially 
diluted sapecin B were incubated. After precipitaiting the immune- 
complex, the radioactivity in the supernatant was measured. Radioac- 
tivity in the supernatant increased linearly with increase in the amount 
of unlabeled sapecin B. For determination f the amount of sapecin B 
in the sample, serially diluted samples were added to the reaction mix- 
ture instead of sapecin B. The amount of sapecin B was determined 
from the dose~esponse curve obtained with unlabeled sapecin B. 
2.5. Other methods 
DNA manipulations including restriction enzyme digestion, gel elec- 
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trophoresis, DNA ligation, plasmid isolation and E. eoli transforma- 
tion were carried out by standard methods. Immunoblot analysis was 
performed as described before [16]. Protein was determined by the 
method of Lowry et al. [17]. 
3. Results 
3.1. cDNA cloning of  sapecin B 
cDNA cloning of sapecin B was performed by repeated PCR 
using an NIH-Sape-4 cDNA library as a template. The eight 
primers and their orientations used for PCR are summarized 
in Fig. 1 with the determined structural o ganization ofsapecin 
B cDNA. We first obtained cDNA corresponding to sapecin 
B. Then we performed two PCR experiments to determine the 
5'- and Y-untranslated regions of sapecin B cDNA. Finally, we 
performed PCR with primers of the 3'- and Y-ends of sapecin 
B cDNA. This PCR product was ligated with a plasmid vector 
and transformed into E. coli. We selected hybridization-posi- 
tive clones, isolated plasmids, and determined the sequences of
their inserts. From these experiments, we determined the com- 
plete sequence of sapecin B cDNA to be as shown in Fig. 2 with 
the putative amino acid sequence. 
This cDNA contained an open reading frame of 264 nucleo- 
tides corresponding to 88 amino acid residues. The amino acid 
sequence of sapecin B was located in the carboxyl terminal of 
this precursor protein. Judging from the hydropathy profile 
(data not shown) and specificity of signal peptidase of Sarco- 
phaga, we concluded that the first 24 residues are a signal 
sequence. Thus, the intervening 30 residues correspond to a 
prosegment. A common potential cleavage signal, Lys-Arg, 
was located between sapecin B and the prosegment. This organ- 
ization of sapecin B cDNA was the same as that of sapecin 
cDNA [8]. 
3.2. Expression of  the sapecin B gene in an acute phase 
Previously, we demonstrated that the sapecin gene was pref- 
erentially expressed in the hemocytes and fat body when the 
larval body wall was injured [8]. Under the same conditions, we 
examined expression of the sapecin B gene by Northern blot 
hybridization. As shown in Fig. 3A, sapecin B mRNA was 
detected almost exclusively in the fat body of injured larvae. 
Therefore, expression of the sapecin B gene is different from 
that of the sapecin gene (Fig. 3B). 
To confirm the synthesis of sapecin B in the fat body, we 
measured the amount of sapecin B in the fat body and hemo- 
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Fig. 1. Strategy of cDNA cloning of sapecin B by PCR. The structural 
organization ofcloned cDNA is shown at the top. S and P indicate the 
signal sequence and prosegment, respectively. Horizontal lines show 
Okayama-Berg vectors. Sequential PCR was performed with the indi- 
cated primers. Arrows show primers with their orientations. 
1 ATACAGTTTATAAC TCTTCTTGAAACTATTCAGAAATCATTTAAAAATTAAAATAAATAA 
61 ~TCAAAATGAAATTTTT~CGAGCTTGCTGTTGCTTTTTGTCGTTGT~TGGTGTCCGC 
1 M K F L T S L L L L F V V V M V S A  
121 TGTG~CTTGTCTATGGCT~GG~TCTGCAAATCAGTT~CGG~CGATTAC~G~CT 
19 V N L S M A K E S A N Q L T E R L Q E L  
181 TGATGGTGCGGCTATAC~G~CCTGCAGAGCTG~TAGACATAAACGTCTTACGTGCGA 
39 D G A A I Q E P A E L N R H K R I  
241 ~TTGATCGTTCCCTTTGTTTGCTCCATTGTAGACTAAAAGGATACTTGCGTGCATATTG 
301 TAGTCAGCAAAAAGTTTGTAGATGTGTAC~TAAAATTAAAATT~TTAAAAAATAAAA~ 
79 • ~ = - * 
361 AAATATTTTT~GAAAAATTTTAAAAAAAAAAAAAAAAA 
Fig. 2. Nucleotide sequence of sapecin B cDNA. The deduced amino 
acid sequence of the precursor protein is shown below the nucleotide 
sequence. The sequence of sapecin B is shaded. Amino acid residues are 
numbered from the first Met residue. The putative signal sequence, 
potential processing signal, and poly(A) addition signals are under- 
lined. The asterisk indicates the termination codon. 
lymph with time after injury by radioimmunoassay. As shown 
in Fig. 4, the amounts of sapecin B in the fat body and hemo- 
lymph were very low at time 0, but increased rapidly to maxima 
after 20 h. Then they decreased gradually, but significant 
amounts of sapecin B were detected even after 80 h. Therefore, 
we concluded that sapecin B is synthesized in the fat body in 
response to body injury, and secreted into the hemolymph to 
prevent bacterial infection. 
3.3. Presence of  sapecin B, but not sapecin, in the brain of normal 
larvae 
Previously we demonstrated that, like charybdotoxin, sape- 
cin B inhibited calcium-activated potassium channels of rat 
cerebella Purkinje cells [6]. These results uggested that sapecin 
B is a regulator of potassium channels in this insect. To examine 
this possibility, we tried Northern blot hybridization with brain 
of naive larvae. However, extraction of intact RNA from the 
brain was technically difficult. Therefore, we tested for sapecin 
B in the brain by radioimmunoassay. As summarized in Table 
1, sapecin B, but not sapecin, was detected in the brain of naive 
larvae. A significant amount of sapecin was detected in the 
brain of injured larvae, but this may have been due to hemo- 
lymph contaminating the brain preparation, since sapecin is 
induced in the hemolymph when the body wall is injured. 
(A) (B) 
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Fig. 3. Detections ofsapecin B and sapecin mRNA. RNA was extracted 
from fat body and hemocytes, and subjected toNorthern blot hybridi- 
zation with sapecin B cDNA (A) and sapecin cDNA (B) as probes. Each 
lane contained 10/.tg of RNA. Lane 1 = fat body f naive larvae; lane 
2 = hemocytes of naive larvae; lane 3 = fat body of injured larvae; lane 
4 = hemocytes of injured larvae. Sapecin B a d sapecin cDNA (each 
30 pg) were electrophoresed in lanes B and S, respectively. The fat body 
and hemocytes were collected 6 h after injury of larvae. 
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Fig. 4. Change in the amount of sapecin B in response to body injury. 
Larvae were injured at time 0. The fat body and hemolymph were 
collected at the indicated times after injury, and contents of sapecin B
were measured by radioimmunoassay. Each point represents he mean 
of duplicate measurements with deviation. (a) Hemolymph; (b) fat 
body. 
4. D iscuss ion  
In this study, we found that the structural organization of 
sapecin B eDNA was the same as that of sapecin cDNA. 
Namely, it consisted of a signal peptide, prosegrnent and sape- 
cin B. When the sequence of signal peptide and prosegment of 
the precursor of sapecin B is compared with that of the same 
region of the precursor of sapecin, the maximal sequence iden- 
tity was less than 20%, which was much less than identity 
between sapecin and sapecin B [5]. Thus, if sapecin, sapecin B 
and sapecin C are derived from a common ancestral gene, the 
sapecin B gene seems to have evolved ifferently from the genes 
for sapecin and sapecin C. 
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Table 1 
Contents of sapecin B and sapecin in larval brain. Means of duplicate 
measurements are given with deviations 
Sapecin B (ng/mg) Sapecin (ng/mg) 
Normal arvae 4.24 _+ 0.19 0.04 + 0.01 
Injured larvae* 2.49 _+ 0.25 1.06 _+ 0.09 
*Brain was collected 24 h after injury. 
We found that sapecin B, but not sapecin, is present in the 
brain of normal arvae. Thus sapecin B in the brain is likely to 
regulate potassium channels. Nothing is known about potas- 
sium channels in Sarcophaga brain, but recently potassium 
channels were identified in Drosophila [18,19]. We assume that 
sapecin B is a bifunctional molecule: in normal larvae, it may 
be expressed in the brain to regulate potassium channels, while 
when the body wall is injured, it may be rapidly synthesized in
the fat body and secreted into hemolymph to prevent bacterial 
infection. 
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